IN2012DN02759A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02759A
IN2012DN02759A IN2759DEN2012A IN2012DN02759A IN 2012DN02759 A IN2012DN02759 A IN 2012DN02759A IN 2759DEN2012 A IN2759DEN2012 A IN 2759DEN2012A IN 2012DN02759 A IN2012DN02759 A IN 2012DN02759A
Authority
IN
India
Prior art keywords
neonate
intestinal
nervous system
system development
glutamine dipeptide
Prior art date
Application number
Other languages
English (en)
Inventor
C Anthony Joshua
Morris Kristin
Grant Maria
Neu Joseph
Original Assignee
Mead Johnson Nutrition Co
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson Nutrition Co, Univ Florida filed Critical Mead Johnson Nutrition Co
Publication of IN2012DN02759A publication Critical patent/IN2012DN02759A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
IN2759DEN2012 2009-10-14 2010-10-14 IN2012DN02759A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/578,922 US20110086809A1 (en) 2009-10-14 2009-10-14 Enteral Administration Of Arginine-Glutamine Dipeptide To Support Retinal, Intestinal, Or Nervous System Development
PCT/US2010/052585 WO2011047107A1 (en) 2009-10-14 2010-10-14 Enteral administration of arginine-glutamine dipeptide to support retinal, intestinal, or nervous system development

Publications (1)

Publication Number Publication Date
IN2012DN02759A true IN2012DN02759A (de) 2015-09-18

Family

ID=43855324

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2759DEN2012 IN2012DN02759A (de) 2009-10-14 2010-10-14

Country Status (12)

Country Link
US (1) US20110086809A1 (de)
EP (1) EP2488191A1 (de)
CN (1) CN102573878A (de)
BR (1) BR112012008814A2 (de)
CA (1) CA2777240A1 (de)
CO (1) CO6531433A2 (de)
EC (1) ECSP12011899A (de)
IN (1) IN2012DN02759A (de)
MX (1) MX2012003725A (de)
RU (1) RU2012119719A (de)
SG (1) SG179040A1 (de)
WO (1) WO2011047107A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2612560A1 (de) * 2012-01-09 2013-07-10 N.V. Nutricia Glutaminangereicherte Ernährungszusammensetzung für frühgeborene Kinder
ES2633787T3 (es) 2012-01-09 2017-09-25 N.V. Nutricia Composición nutritiva enriquecida con glutamina para bebés pretérmino
IN2015DN03862A (de) * 2012-11-02 2015-10-02 Nutricia Nv
RU2619294C2 (ru) * 2013-01-09 2017-05-15 Н.В. Нютрисиа Улучшение познавательных способностей недоношенных детей, имеющих низкую массу для своего гестационного возраста
WO2015160234A1 (en) * 2014-04-17 2015-10-22 N.V. Nutricia Composition for brain improvement
JP2024542280A (ja) * 2021-12-01 2024-11-13 セインダ ファーマシューティカル グアンジョウ コーポレイション アラニル-グルタミンおよびアラニル-グルタミンを含む眼科用組成物の新規な使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060229256A1 (en) * 2003-09-26 2006-10-12 Bristol-Myers Squibb Company Enternal administration of arginine and glutamine for abnormal vascular proliferation
WO2005030243A1 (en) * 2003-09-26 2005-04-07 Bristol Myers Squibb Company Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
WO2009052106A2 (en) * 2007-10-14 2009-04-23 University Of Florida Research Foundation Inc. Formulation to improve gastrointestinal function

Also Published As

Publication number Publication date
US20110086809A1 (en) 2011-04-14
EP2488191A1 (de) 2012-08-22
BR112012008814A2 (pt) 2019-09-24
WO2011047107A1 (en) 2011-04-21
MX2012003725A (es) 2012-07-10
CA2777240A1 (en) 2011-04-21
CO6531433A2 (es) 2012-09-28
SG179040A1 (en) 2012-04-27
CN102573878A (zh) 2012-07-11
RU2012119719A (ru) 2013-11-20
ECSP12011899A (es) 2012-07-31

Similar Documents

Publication Publication Date Title
TR201903336T4 (tr) Fermantasyonda gelişmiş karbon yakalama.
WO2010000127A9 (en) Method to induce and expand therapeutic alloantigen- specific human regulatory t cells in large-scale
AP2012006162A0 (en) Apparatus and process for fermentation of biomass hydrolysate.
EP2475763A4 (de) System und verfahren zur bearbeitung von gasemissionen und abwässern sowie zur produktion von algenbiomasse
SG179040A1 (en) Enteral administration of arginine-glutamine dipeptide to support retinal, intestinal, or nervous system development
MX2012002456A (es) Nuevas formas de un compuesto multiciclico.
MX2009011022A (es) Uso de sustratos como chaperonas farmacologicas.
NZ599173A (en) Marker protein for type 2 diabetes
UA41936U (ru) Способ лечения крауроза вульвы в детском возрасте
UA34798U (ru) Способ коррекции состояния макрофагальной фагоцитирующей системы у больных с соматоформными депрессивными расстройствами
UA49567U (ru) Способ лечения хронических заболеваний кишечника у больных гипертонической болезнью
UA34796U (ru) Способ коррекции состояния макрофагальной системы у больных с синдромом повышенной утомляемости
UA40108U (ru) Способ патогенетического лечения туберкулеза у детей
UA34804U (ru) Способ коррекции синдрома метаболической интоксикации у больных фебрильной шизофренией
UA44840U (ru) Способ формирования межкишечного анастомоза по типу "бок в бок"
UA93309C2 (ru) Способ получения препарата для профилактики moho- и полигипомикроэлементозов у вольных свиноматок
UA35017U (ru) Способ фитотерапии синдрома экологически обусловленного иммунодефицита
UA47777U (ru) Учебная модель «звездные многогранники лося»
UA35047U (ru) Способ проведения оздоровительной гимнастики
UA34801U (ru) Способ коррекции состояния макрофагальной фагоцитирующей системы у больных туберкулезом легких
UA34813U (ru) Способ иммунореабилитации реконвалесцентов острого тонзиллита с наличием вторичных иммунодефицитных состояний
UA42356U (en) Technique for hemorrhoidectomy
UA59660U (ru) Способ коррекции нарушений перекисных процессов в организме
UA39877U (uk) Спосіб ортопедичного лікування хворих з частковими дефектами зубних рядів та патологією серцево-судинної системи
UA41924U (ru) Способ комплексного лечения угревой болезни у взрослых